Original Article
CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer
Laduona Wang, Yijun Wu, Kai Kang, Xuanwei Zhang, Ren Luo, Zegui Tu, Yue Zheng, Guo Lin, Hui Wang, Min Tang, Min Yu, Bingwen Zou, Ruizhan Tong, Linglu Yi, Feifei Na, Jianxin Xue, Zhuoran Yao, You Lu
